Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Lai

Showing results (81-90 of 207) with videos related to

Pageof 21
Sort By:
The American Journal of Pathology|May 27, 2004
Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphomaGeorge Z Rassidakis, Raymond Lai, Marco Herling, et al.
Molecular Pharmaceutics|December 25, 2009
Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapyOmmoleila Molavi, Abdullah Mahmud, Samar Hamdy, et al.
The American Journal of Surgical Pathology|October 3, 2002
Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic featuresFiliz Sen, L Jeffrey Medeiros, Di Lu, et al.
BMC Cancer|April 4, 2018
Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphomaChengsheng Wu, Nidhi Gupta, Yung-Hsing Huang, et al.
Cancers|October 18, 2017
STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell LineHoda Soleymani Abyaneh, Nidhi Gupta, Aneta Radziwon-Balicka, et al.
Journal of Biomedical Materials Research. Part A|October 30, 2013
Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapyArash Falamarzian, Hamidreza Montazeri Aliabadi, Ommoleila Molavi, et al.
Pharmaceutical Biology|December 29, 2016
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapyOmmoleila Molavi, Farzaneh Narimani, Farshid Asiaee, et al.
Journal of Signal Transduction|August 2, 2012
NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine KinasesJoel D Pearson, Jason K H Lee, Julinor T C Bacani, et al.
Cellular Signalling|October 2, 2012
Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphomaSamar A Hegazy, Abdulraheem Alshareef, Pascal Gelebart, et al.
International Journal of Clinical and Experimental Pathology|February 18, 2011
NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphomaJoel D Pearson, Jason K H Lee, Julinor T C Bacani, et al.
Pageof 21

Showing results (81-90 of 207) with videos related to

Sort By:
Pageof 21
The American Journal of Pathology|May 27, 2004
Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphomaGeorge Z Rassidakis, Raymond Lai, Marco Herling, et al.
Molecular Pharmaceutics|December 25, 2009
Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapyOmmoleila Molavi, Abdullah Mahmud, Samar Hamdy, et al.
The American Journal of Surgical Pathology|October 3, 2002
Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic featuresFiliz Sen, L Jeffrey Medeiros, Di Lu, et al.
BMC Cancer|April 4, 2018
Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphomaChengsheng Wu, Nidhi Gupta, Yung-Hsing Huang, et al.
Cancers|October 18, 2017
STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell LineHoda Soleymani Abyaneh, Nidhi Gupta, Aneta Radziwon-Balicka, et al.
Journal of Biomedical Materials Research. Part A|October 30, 2013
Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapyArash Falamarzian, Hamidreza Montazeri Aliabadi, Ommoleila Molavi, et al.
Pharmaceutical Biology|December 29, 2016
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapyOmmoleila Molavi, Farzaneh Narimani, Farshid Asiaee, et al.
Journal of Signal Transduction|August 2, 2012
NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine KinasesJoel D Pearson, Jason K H Lee, Julinor T C Bacani, et al.
Cellular Signalling|October 2, 2012
Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphomaSamar A Hegazy, Abdulraheem Alshareef, Pascal Gelebart, et al.
International Journal of Clinical and Experimental Pathology|February 18, 2011
NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphomaJoel D Pearson, Jason K H Lee, Julinor T C Bacani, et al.
Pageof 21